Stay updated on IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Sign up to get notified when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.

Latest updates to the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page footer now shows Revision: v3.3.2, replacing Revision: v3.3.1. This update does not affect the study data or page functionality.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.1. There are no visible changes to study details or functionality.SummaryDifference0.1%

- Check26 days agoChange DetectedFunding-status notice removed from the page. It was a non-core, informational message and does not affect the study details.SummaryDifference0.4%

- Check40 days agoChange DetectedThe new screenshot shows only minor layout and labeling adjustments on the study details page, with core content and eligibility criteria unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check69 days agoChange Detected- Added a government-operating-status notice and updated operating status links, and bumped revision to v3.2.0. - Removed a specific resource reference: Genetic and Rare Diseases Information Center resources: Primary biliary cholangitis (now outdated).SummaryDifference6%

- Check76 days agoChange DetectedThe page has updated the revision from v3.0.2 to v3.1.0, indicating a version upgrade.SummaryDifference0.1%

Stay in the know with updates to IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.